COVID-19 News

Navigating the Challenges and Regulatory Landscape of Neoantigen Peptide Cancer Vaccines

Structural Properties of Pangolin-CoV Spike Glycoprotein Reveal Evolutionary Insight of SARS-CoV-2

The animal reservoir from SARS-CoV-2

Learn about CHO cells’ role in producing SARS-CoV-2 proteins for development of vaccines and neutralizing antibody drugs during the COVID-19 pandemic.

Learn about the central role of neutralizing antibodies to SARS-CoV-2 spike’s protein in treatment, diagnostics and evaluation of responses to infection or vaccines and how cPass has been authorized by the FDA to measure neutralizing antibodies in convale

To no one's surprise by now, SARS-CoV-2 is very efficient at infecting our lungs.

Learn about newly characterized SARS-CoV-2 variants and what scientists have learned about the efficacy of mRNA vaccines in the face of increasing viral mutations.

Selection and Attributes of Synthetic Nanobodies that Effectively Neutralize SARS-CoV-2

FDA Authorized GenScript's cPass™ Kit

When he reached his office at IAVI, once known as the International AIDS Vaccine Initiative, on the eighth floor of the Brooklyn Army Terminal, his fellow scientists wanted to know: Would they be working on a COVID-19 vaccine?